Transgene
Clinical trials sponsored by Transgene, explained in plain language.
-
New Two-Pronged attack tested for tough HPV cancers
Disease control OngoingThis study is testing a new combination of two drugs, TG4001 and avelumab, for people with advanced HPV-16 positive cancers that have returned or spread. The goal is to see if using these drugs together is safe and more effective at controlling the cancer than using avelumab alon…
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Personalized vaccine trial aims to train immune system to fight cancer recurrence
Disease control OngoingThis trial is testing a personalized immunotherapy called TG4050 in patients with advanced head and neck cancer who have completed initial treatment. The goal is to see if this vaccine, designed to target each patient's specific cancer mutations, is safe and can help prevent the …
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC